OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
Chanping You, Man‐Hong Leung, W.H. Tsang, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 72-72
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 47

Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review
Boya Lu, Elango Natarajan, Hanumantha Rao Balaji Raghavendran, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 38

New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer
Nidhi Jain Singhai, Rahul Maheshwari, Kapil Khatri
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104880-104880
Closed Access | Times Cited: 13

Mechanism insights of curcumin and its analogues in cancer: An update
Priyanka Joshi, Kanika Verma, Deepak Kumar Semwal, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5435-5463
Closed Access | Times Cited: 13

Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin Kumar Deshmukh, Sharon Wu, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access

Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer
Anca-Narcisa Neagu, Madhuri Jayathirtha, Danielle Whitham, et al.
Proteomes (2022) Vol. 10, Iss. 4, pp. 35-35
Open Access | Times Cited: 18

Modulating the Activity of Androgen Receptor for Treating Breast Cancer
Chanping You, Ho Tsoi, Ellen P.S. Man, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15342-15342
Open Access | Times Cited: 17

Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
Man Yang, Jiale Sun, Liqiong Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review
Kareena Moar, Anuja Pant, Vikas Saini, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154893-154893
Closed Access | Times Cited: 7

Protein biomarkers for diagnosis of breast cancer
Emeka Iweala, Doris Nnenna Amuji, Faith Chinasaokwu Nnaji
Scientific African (2024) Vol. 25, pp. e02308-e02308
Open Access | Times Cited: 2

Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer
Qing Pan, Dachang Ma, Yi Xiao, et al.
Translational Oncology (2024) Vol. 49, pp. 102081-102081
Open Access | Times Cited: 2

Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
Lingzhi Chen, Yiyuan Liu, Jiehui Cai, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 9

Proteomics techniques in protein biomarker discovery
Mahsa Babaei, Soheila Kashanian, Huang‐Teck Lee, et al.
Quantitative Biology (2024) Vol. 12, Iss. 1, pp. 53-69
Open Access | Times Cited: 1

Ethanolic Extract of Averrhoa carambola Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study
Oscar F. Beas-Guzmán, Ariana Cabrera‐Licona, Gustavo A. Hernández‐Fuentes, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 2-2
Open Access | Times Cited: 1

Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells
Catia Morelli, Chiara Chiodo, Marta C. Nocito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13464-13464
Open Access | Times Cited: 2

Recent Contributions of Mass Spectrometry-Based “Omics” in the Studies of Breast Cancer
Subhrajit Banerjee, Madushmita Hatimuria, Kasturi Sarkar, et al.
Chemical Research in Toxicology (2023) Vol. 37, Iss. 2, pp. 137-180
Closed Access | Times Cited: 2

AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
Mengping Long, Chong You, Qianqian Song, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11468-11468
Open Access | Times Cited: 3

Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans
Oluwadamilola T. Oladeru, Fareed Rajack, Ashwini Esnakula, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1522-1522
Open Access

Androgen receptor expression and clinical characteristics in breast cancer
Dandan Wang, Linhong Jiang, Jian Zhang, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
Danyang Zhou, Mei Li, Mohamed Hussein Yasin, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Breast Cancer Treatment: To tARget or Not? That is the Question
Alexandra Stone, Kevin Lin, Ghanshyam H. Ghelani, et al.
(2023)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top